ANGO: AngioDynamics Inc Long-Term Debt Volume

Graphic logo of AngioDynamics Inc. (ANGO)

AngioDynamics, Inc. (ANGO) maintains a high reputation for developing interventional and oncology systems due to the reliability of its devices. The stock price retrospective reflects long-term debt dynamics, which currently stands at 0.01. Distribution efficiency is achieved by outsourcing sterilization and electronics assembly to third-party contractors. Profit stabilization is supported by the development of the NanoKnife platform and the updating of the surgical catalog.

ANGO AngioDynamics, Inc.: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Analytical breakdowns for AngioDynamics, Inc.

- price and consensus price forecast:
Share Price angiodynamics.com|ANGO - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization AngioDynamics|ANGO - Enterprise Value
- book capitalization data:
Accounting Value per Share AngioDynamics|ANGO - Book Capitalization|Market Capitalization to Book Value Ratio angiodynamics.com|ANGO - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity AngioDynamics, Inc.|ANGO - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital AngioDynamics Inc.|ANGO - Company Aggregate Debts|Debts to Net Assets AngioDynamics|ANGO - Company Long-Term Debt|Company Short-Term Indebtedness AngioDynamics
General company analysis:angiodynamics.com (ANGO)
Mass-produced product of AngioDynamics Inc.

Procuring components from external suppliers for catheter assembly requires stable operating cycle financing for AngioDynamics, Inc. (ANGO). This metric aggregates all long-term credit obligations, measuring the total amount of loans with a maturity exceeding one year. This indicator reflects the debt load and default risk associated with expanding production capacities. By analyzing changes in the issuer's long-term liabilities, an investor can assess the effectiveness of borrowing to drive capitalization growth.

Competitor analysis

Company Long-Term Indebtedness intuitive.com ISRG|Company Long-Term Debts DHR (Danaher)|BDX - Long-Term Debt Volume|STE (STERIS Corporation) - Company Long-Term Debts|West Pharma Corp (WST) - Company Long-Term Liabilities|BAX (Baxter International) - Company Long-Term Debts|Company Long-Term Debts MASI|Company Long-Term Debt Stevanato Group (STVN)|Company Long-Term Debt Teleflex Inc. TFX|Company Long-Term Liabilities Merit Medical Systems Inc|Company Long-Term Loans and Borrowings Nobel Biocare NVST|Company Long-Term Debts ICUI (ICU Medical, Inc.)|XRAY: Long-Term Debt Volume|Company Long-Term Debt LeMaitre Vascular|ATRC (AtriCure Inc) - Company Long-Term Indebtedness|STAA: Company Long-Term Debt|Long-Term Debt Volume niagenbioscience.com (NAGE)|Company Long-Term Liabilities ZimVie Inc.|Amount of Long-Term Liabilities CERS (cerus.com)|Company Long-Term Debt Teknova|MGRM - Company Long-Term Loans and Borrowings|Sharps Tech - Company Long-Term Liabilities|INFU: Company Long-Term Debts|UTMD (Utah Medical Products) - Company Long-Term Debt|KORU Medical (KRMD) - Company Long-Term Liabilities|Company Long-Term Debts NYXH (Nyxoah)|Long-Term Debt MBOT|Company Long-Term Debt Pro-Dex Corp PDEX|Company Long-Term Indebtedness Zentek Corp ZTEK|Company Long-Term Liabilities Elutia Inc. (ELUT)|milestonescientific.com - Amount of Long-Term Liabilities|Company Long-Term Debt NXGL (NEXGEL)|RVP - Long-Term Debt Volume|HBIO: Company Long-Term Debts|FEMY (Femasys Corporation) - Company Long-Term Debts|Company Long-Term Debt Meihua Medical Technologies (MHUA)|Company Long-Term Indebtedness Predictive Oncology Corp|CJMB: Company Long-Term Debts|Long-Term Indebtedness Atrion Corp. (ATRI)|Company Long-Term Debts NURO